https://www.onhealthcare.tech/p/the-fifteen-dollar-arbitration-how-316Thoughts on Healthcare Markets & Technologyen2026-05-29T11:10:53+00:00The Fifteen Dollar Arbitration: How the Final No Surprises Act IDR Operations Rule Cuts Dispute Fees, Rewires Provider & Payer Incentives, and Opens the Door to Arbitration-as-a-Service Business Modelhttps://www.onhealthcare.tech/p/the-fifteen-dollar-arbitration-howThoughts on Healthcare Markets & Technologyen2026-05-29T01:16:14+00:00The Fifteen Dollar Arbitration: How the Final No Surprises Act IDR Operations Rule Cuts Dispute Fees, Rewires Provider & Payer Incentives, and Opens the Door to Arbitration-as-a-Service Business Modelhttps://www.onhealthcare.tech/p/one-infusion-a-permanent-gene-editThoughts on Healthcare Markets & Technologyen2026-05-28T11:02:47+00:00One Infusion. A Permanent Gene Edit. A Lifetime of LDL Lowering. The VERVE-102 NEJM Data, the Lilly Acquisition Thesis, and What It Means.https://www.onhealthcare.tech/p/part-ii-one-infusion-a-permanentThoughts on Healthcare Markets & Technologyen2026-05-28T01:14:59+00:00Part II: One Infusion. A Permanent Gene Edit. A Lifetime of LDL Lowering. The VERVE-102 NEJM Data, the Lilly Acquisition Thesis, and What It Means.https://www.onhealthcare.tech/p/part-i-one-infusion-a-permanent-geneThoughts on Healthcare Markets & Technologyen2026-05-28T01:13:01+00:00Part I: One Infusion. A Permanent Gene Edit. A Lifetime of LDL Lowering. The VERVE-102 NEJM Data, the Lilly Acquisition Thesis, and What It Means.